|
3SBio wants to find a cure for a wide spread of ailments, including cancer and viral and autoimmune diseases. The biopharmaceutical company develops protein-based products for treating diseases in nephrology, oncology, cancer care, and other areas through its Shenyang Sunshine subsidiary. The company's flagship product, EPIAO, is used to increase the amount of red blood cells in patients with anemia. Its newest product, TPIAO, treats a chemotherapy-induced deficiency in blood platelets. Other products include Intefen and Inleusin for leukemia, hepatitis C, and kidney cancer. 3SBio markets its products primarily through distributors in China to physicians, hospitals, clinics, and dialysis centers.
|
| | | Contact Information | |
Address: |
3 A1, Rd. 10, Shenyang Economy & Technology Development Zone
Shenyang, Liaoning 110027, China
| | Phone: | +86-24-2581-1820 | | Fax: | |
|
| Financial
Highlights | | Fiscal Year End: | December |
|
|
Key People
| | • |
Chairman:
Dan Lou
| | • |
CEO and Director:
Jing Lou
| | • |
EVP and COO:
David Chen
|
|
|
